Please ensure Javascript is enabled for purposes of website accessibility

Amazon to Test Warehouse Workers for COVID-19 Every Two Weeks

By Donna Fuscaldo – Jun 9, 2020 at 3:59PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Amazon is gearing up to have warehouse workers take a self-test for the coronavirus using a nasal swab and a video.

Amazon (AMZN 1.20%) is preparing for life in a post-COVID-19 world, gearing up to test warehouse workers for the coronavirus every two weeks. 

CNBC, citing people familiar with the tech stock's plans, reported workers at Amazon's fulfillment centers around the country would have to conduct a self-test using a nasal swap every two weeks. They would be guided through the test via a video with a medical professional nearby to supervise. 

Shelves in a warehouse filled with boxes and two surgical masks hanging from them.


The move is designed to prevent any more outbreaks at its fulfillment centers as stay-at-home orders are lifted across the country. During the peak of the pandemic in the U.S. employees in several of Amazon's warehouses tested positive for the virus. The e-commerce giant is earmarking the $4 billion in operating profit it would normally earn in the second quarter to respond to the pandemic.  

Amazon is also creating diagnostic labs in many of its locations to analyze test samples to ascertain if an employee is negative or positive. The first two testing sites will be located in Sunnyvale, California, and Kentucky, reported CNBC. Employees who test positive will be referred to GrandRounds, a telemedicine start-up that will provide virtual consultations.

In order for Amazon to test all its warehouse workers every two weeks, it will need millions of tests. To meet that end, Amazon's CEO Jeff Bezos laid out plans to create its own COVID-19 diagnostic test in the company's annual letter to shareholders released in April. At the time Bezos said research scientists, procurement specialists, and software engineers have refocused their roles to create a test for the virus. Amazon had already begun assembling the equipment needed to build its first lab in April.  

John Mackey, CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool's board of directors. Donna Fuscaldo has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Amazon and recommends the following options: short January 2022 $1940 calls on Amazon and long January 2022 $1920 calls on Amazon. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned, Inc. Stock Quote, Inc.
$115.15 (1.20%) $1.37

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/26/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.